Clinical trials
Urinary Incontinence, Stress trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 3 |
| Peking Union Medical College Hospital | 3 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Hebei General Hospital | 1 |
| Hong Kong Metropolitan University | 1 |
| Jie Li | 1 |
| Jinan Military General Hospital | 1 |
| Medprin Regenerative Medical Technologies Co., Ltd. | 1 |
| Peking University People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Incontinence, Stress | 22 |
| Pelvic Organ Prolapse | 2 |
| Multiple Endocrine Neoplasia Type 1 | 1 |
| Prostatic Hyperplasia | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.